Table of Contents
1 Table Of Contents 2 1.1 List of Tables 5 1.2 List of Figures 6 2
Atrial Fibrillation Pipeline Technology and Market Forecasts to 2015 7 2.1
Introductions and Definitions 7 2.1.1 Electrophysiology 7 2.1.1.1
Electrophysiology Ablation Catheter 7 2.1.1.2 Electrophysiology Diagnostic
Catheter 7 2.1.1.3 Electrophysiology Lab Systems 7 2.2 Executive
Summary 8 3 Atrial Fibrillation Technology Landscape 9 3.1 Atrial
Fibrillation: Overview 9 3.2 Atrial Fibrillation Ablation 10 3.3
Atrial Fibrillation Clinical Trials 11 3.3.1 Comparison of ablation to
drug therapy for atrial fibrillation 11 3.3.2 Catheter Ablation Versus
Anti-arrhythmic Drug Therapy for Atrial Fibrillation 12 3.3.3 Study of
Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation 12
3.3.4 Ablation or Surgery for Atrial Fibrillation (AF) Treatment 13 3.3.5
Tailored Treatment of Permanent Atrial Fibrillation 13 3.4 Comparative
Effectiveness Research for Radiofrequency Catheter Ablation of Atrial
Fibrillation 14 4 Global Atrial Fibrillation Ablation Catheters Market
15 4.1 Market Overview 15 4.2 Atrial Fibrillation Ablation Catheters
Cross Country Analysis of Revenue 16 4.3 Atrial Fibrillation Ablation
Catheters Market Trends 17 4.3.1 Atrial Fibrillation Ablation Catheters
Market Drivers 17 4.3.2 Atrial Fibrillation Market Restraints 17 4.4
Atrial Fibrillation Ablation Catheters Emerging Trends 18 5 Global
Electrophysiology Market 19 5.1 Market Overview 19 5.2
Electrophysiology Cross Segment Analysis 21 5.3 Electrophysiology Cross
Country Analysis 23 5.4 Competitive Landscape 25 6 Atrial Fibrillation
Ablation Catheters Pipeline Products 27 6.1 TactiCath 27 6.1.1 Product
Status 27 6.1.2 Product Description 27 6.1.3 Clinical Trial 27 6.2
Pulmonary Vein Ablation Catheter 28 6.2.1 Product Status 28 6.2.2
Product Description 28 6.2.3 Clinical Trial One 28 6.2.4 Clinical
Trial Two 29 6.2.5 Clinical Trial Three 29 6.3 CoolFlex Ablation
Catheter 30 6.3.1 Product Status 30 6.3.2 Product Description 30
6.4 Cryo Balloon Catheter 31 6.4.1 Product Status 31 6.4.2 Product
Description 31 6.5 Multi-Array Ablation Catheter 32 6.5.1 Product
Status 32 6.5.2 Product Description 32 6.5.3 Clinical Trial 33 7
Global Atrial Fibrillation Ablation Catheters Pipeline Product Summary 34
8 Future Outlook 35 9 Appendix 36 9.1 Research Methodology 36 9.2
Coverage 37 9.3 Secondary Research 38 9.4 Primary Research 38 9.5
Models 39 9.6 Forecasts 39 9.7 Expert Panels 39 9.8 GlobalData
Consulting 40 9.9 Contact Us 40 9.10 Disclaimer 40 1.1 List
of Tables Table 1: Atrial Fibrillation Ablation Catheters, Global, Revenue
($ m), 2001-2015 15 Table 2: Atrial Fibrillation Ablation Catheters Cross
Country Analysis of Revenue, 2008 16 Table 3: Electrophysiology, Global,
Value ($ m), 2001 - 2008 20 Table 4: Electrophysiology, Global, Value ($
m), 2008 - 2015 20 Table 5: Electrophysiology, Global, Cross Segment
Analysis, 2008 21 Table 6: Electrophysiology Cross Country Analysis of
Revenue, 2008 24 Table 7: NAVISTAR-First Ablation Catheter For Atrial
Fibrillation in Market 26 Table 8: TactiCath, Product Status 27
Table 9: TactiCath, Product Description 27 Table 10: TactiCath
Clinical Trial 27 Table 11: Pulmonary Vein Ablation Catheter, Product
Status 28 Table 12: Pulmonary Vein Ablation Catheter, Product
Description 28 Table 13: Pulmonary Vein Ablation Catheter Clinical
Trial One 28 Table 14: Pulmonary Vein Ablation Catheter Clinical
Trial Two 29 Table 15: Pulmonary Vein Ablation Catheter Clinical
Trial Three 29 Table 16: CoolFlex Ablation Catheter, Product Status
30 Table 17: CoolFlex Ablation Catheter, Product Description 30
Table 18: Cryo Balloon Catheter, Product Status 31 Table 19:
Cryo Balloon Catheter, Product Description 31 Table 20: Multi-Array
Ablation Catheter, Product Status 32 Table 21: Multi-Array Ablation
Catheter, Product Description 32 Table 22: Multi-Array Ablation
Catheter Clinical Trial 33 Table 23: Global Atrial Fibrillation Ablation
Catheters Pipeline Product Summary 34 1.2 List of Figures Figure
1: Heart Rhythm Disorder and Treatment Methods 10 Figure 2: Atrial
Fibrillation Treatment Methodology 10 Figure 3: Atrial Fibrillation
Ablation Catheters, Global, Revenue ($ m), 2001-2015 15 Figure 4: Atrial
Fibrillation Ablation Catheters Cross Country Analysis of Revenue, 2008 16
Figure 5: Electrophysiology, Global, Revenue ($ m), 2001-2015 19 Figure 6:
Electrophysiology, Global, Cross Segment Analysis, 2008 21 Figure 7:
Electrophysiology Cross Country Analysis of Revenue, 2008 23 Figure 8:
Electrophysiology, Company Shares, Global, 2008 25 Figure 9: GlobalData
Methodology 37
|